Gephyrin alterations due to protein accumulation stress are reduced by the lysosomal modulator Z-Phe-Ala-diazomethylketone.

Journal of Molecular Neuroscience : MN
Sophia Ryzhikov, Ben A Bahr

Abstract

Inhibitory neurotransmission is important for brain function and requires specific transmitter receptors that are organized in synaptic domains. Gephyrin is a cytoskeletal organization protein that binds tubulin and plays an important role in clustering and organizing select inhibitory neurotransmitter receptors. Here, we tested if gephyrin is altered by protein accumulation stress that is common in age-related neurodegenerative disorders. For this, we used the hippocampal slice model that has been shown to exhibit chloroquine (CQN)-induced protein accumulation, microtubule destabilization, transport failure, and declines in excitatory neurotransmitter receptors and their responses. In addition to the decreases in excitatory receptor subunits and other glutamatergic markers, we found that gephyrin isoforms were reduced across the CQN treatment period. Associated with this decline in gephyrin levels was the production of three gephyrin breakdown products (GBDPs) of 30, 38, and 48 kDa. The induced effects on gephyrin were tested for evidence of recovery through enhancement of lysosomal function that is known to promote protein clearance and microtubule integrity. Using the lysosomal modulator Z-Phe-Ala-diazomethylketone (PADK), g...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G L CaporasoP Greengard
May 1, 1992·Neurobiology of Aging·W G HonerP Davies
Jun 19, 1995·The Journal of Comparative Neurology·M Sassoè-PognettoH Wässle
Feb 1, 1994·Stroke; a Journal of Cerebral Circulation·J J VornovJ T Coyle
Sep 18, 1997·Journal of Neuropathology and Experimental Neurology·M D IkonomovicD M Armstrong
Nov 21, 2000·Molecular and Cellular Neurosciences·J MeierC Vannier
Feb 24, 2001·Annals of the New York Academy of Sciences·P Davies
May 23, 2001·Nature Neuroscience·A M Craig, H Boudin
Jul 5, 2001·Cellular and Molecular Life Sciences : CMLS·P Legendre
Jul 20, 2002·Journal of Neuropathology and Experimental Neurology·Jennifer BendiskeBen A Bahr
Oct 23, 2002·Journal of Neurochemistry·Ben A Bahr, Jennifer Bendiske
Jan 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sabine LéviAnn Marie Craig
Feb 6, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cyril HanusAntoine Triller
May 13, 2004·Acta Neuropathologica·Ebru Caba, Ben A Bahr
Feb 1, 2005·European Journal of Pharmacology·David A KaranianBen A Bahr
Feb 26, 2005·Science·Gorazd B StokinLawrence S B Goldstein
Mar 2, 2005·The Journal of Comparative Neurology·Barbara StudlerJean-Marc Fritschy
Aug 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David A KaranianBen A Bahr
Nov 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tija C JacobStephen J Moss
Nov 18, 2005·Neurobiology of Aging·Stephen W ScheffElliott J Mufson
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Donald M CasparyLarry F Hughes

❮ Previous
Next ❯

Citations

Jan 25, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Vinogran NaidooBen A Bahr
Jun 24, 2014·Rejuvenation Research·Ben A Bahr
Nov 12, 2010·Journal of Molecular Neuroscience : MN·Vinogran NaidooBen A Bahr
Nov 8, 2012·ACS Medicinal Chemistry Letters·Kishore ViswanathanDennis L Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.